Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability and Feasibility of Modified HPV Vaccine Schedule in FSWs
NCT00925288Phase 4Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Oct 2009
- Primary completion
- Aug 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of qHPV vaccine in human papillomavirus infection, sponsored by Johns Hopkins Bloomberg School of Public Health. Started Oct 2009; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00925288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925288.